Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis.

Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Abstract Text:

    li-juan zhangLi-Juan Zhang,wei-da zhengWei-Da Zheng,yun-xin chenYun-Xin Chen,yue-hong huangYue-Hong Huang,zhi-xin chenZhi-Xin Chen,sheng-jun zhangSheng-Jun Zhang,mei-na shiMei-Na Shi,xiao-zhong wangXiao-Zhong Wang,

    BACKGROUND/AIMS: To study the effects of interleukin-10 on hepatic stellate cells and liver tissue in experimental rats hepatic fibrosis. METHODOLOGY: Rat hepatic fibrosis model induced by carbon tetrachloride was established. Liver tissues were harvested from the rats administered CCl4 with or without IL-10 treatment and the animals of the control group. The expression of TGF-beta1, MMP-2 and TIMP-1 in the liver tissues was measured by S-P immunohistochemistry. In addition, another model was established; HSCs in rats in each group were isolated. RT-PCR was employed to analyze TGF-beta1, MMP-2 and TIMP-1 mRNA expression in cells and immunocytochemistry was performed to detect protein expression of alpha-SMA, NF-kappaB, TGF-beta1, MMP-2 and TIMP-1 in HSCs. RESULTS: Rat hepatic fibrosis was developed successfully. The fibrosis changes were partially reversed by simultaneous administration of IL-10. The positive signals of TGF-beta1, MMP-2 and TIMP-1 were observed more frequently (P<0.05) in the CCl4-treated group compared to those in the IL-10-treated group and the control group. HSCs were successfully isolated. TGF-beta1, MMP-2 and TIMP-1 mRNA in HSCs increased obviously during the course of hepatic fibrosis, and their levels were decreased after the treatment with IL-10 (P<0.05). The immunocytochemistry positive levels for TGF-beta1, MMP-2, TIMP-1, alpha-SMA and NF-kappaB in the fibrogenesis group were increased significantly compared to the normal group (P<0.01). The positive signals decreased significantly (P<0.05) after the treatment with IL-10. CONCLUSIONS: The expression of TGF-beta1, MMP-2 and TIMP-1 increased in liver or in HSC of hepatic fibrosis rats and decreased after treatment with IL-10. The IL-10 could inhibit the activation of HSCs and make an antifibrogenic process come into effect in this way.

    Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Publishing Authors By Initials

    lj zhangLJ Zhang,wd zhengWD Zheng,yx chenYX Chen,yh huangYH Huang,zx chenZX Chen,sj zhangSJ Zhang,mn shiMN Shi,xz wangXZ Wang,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Hepato-gastroenterology

    VOLUME: 54

    Page Numbers: 2092-8

    Journal Abbreviation: Hepatogastroenterology

    ISSN: 0172-6390

    DAY: 6

    MONTH: 02

    YEAR: 2008

    Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8007849

    Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis.

    AFFILIATION: Department of Gastroenterology, Union Hospital of Fujian Medical University, Fuzhou 350001, Fujian Province, China.

    Country: Greece

    Greece Research PublicationGreece Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Hepatogastroenterology

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News